Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.

Journal of cancer research and therapeutics - 1 Jan 2000

Zhu Hongcheng, Cao Songyu, Liu Yun, Ding Xiangxiang, Wu Qianqian, Ma Hongxia

Abstract excerpt

INTRODUCTION: The Xeroderma pigmentosum group D (XPD, also referred to as excision repair cross complementing gene 2, ERCC2) is one of key genes involved in nucleotide excision repair and two potentially functional polymorphisms of XPD (Asp312Asn and Lys751Gln) have been widely investigated in various cancers including prostate cancer. However, the results were conflicting rather than conclusive. AIMS: Thus, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ERCC2 gene
Share to Gene Frequency
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Polymorphism, Genetic

Share to Prostatic Neoplasms

Share to Xeroderma Pigmentosum Group D Protein

Source

Identifiers

PMID: 23771356
DOI: 10.4103/0973-1482.113345

Genes

ERCC2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.PMID 23771356Read ↗

Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

Impact of two common xeroderma pigmentosum group D (XPD) gene polymorphisms on risk of prostate cancer.Semantic proximity Read ↗

XPD Asp312Asn polymorphism is a risk factor for prostate cancer.Semantic proximity Read ↗

Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.Semantic proximity Read ↗

Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies.Semantic proximity Read ↗

Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.Semantic proximity Read ↗

Polymorphisms in XPD and hOGG1 and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

Association between XPD Lys751Gln polymorphism and bladder cancer susceptibility: an updated and cumulative meta-analysis based on 6,836 cases and 8,251 controls.Semantic proximity Read ↗

The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis.Semantic proximity Read ↗

XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

Effects of Xeroderma pigmentosum group C polymorphism on the likelihood of prostate cancer.Semantic proximity Read ↗

XPD Lys(751)Gln and Asp (312)Asn polymorphisms and bladder cancer risk: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.